Literature DB >> 23433494

How and why Toxoplasma makes us crazy.

Jaroslav Flegr1.   

Abstract

For a long time, a latent toxoplasmosis, the lifelong presence of dormant stages of Toxoplasma in various tissues, including the brain, was considered harmless for immunocompetent persons. Within the past 10 years, however, many independent studies have shown that this parasitic disease, with a worldwide prevalence of about 30%, could be indirectly responsible for hundreds of thousands of deaths due to its effects on the rate of traffic and workplace accidents, and also suicides. Moreover, latent toxoplasmosis is probably one of the most important risk factors for schizophrenia. At least some of these effects, possibly mediated by increased dopamine and decreased tryptophan, are products of manipulation activity by Toxoplasma aiming to increase the probability of transmission from intermediate to definitive host through predation.
Copyright © 2013. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23433494     DOI: 10.1016/j.pt.2013.01.007

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN: 1471-4922


  51 in total

Review 1.  Toxoplasma gondii: Biological Parameters of the Connection to Schizophrenia.

Authors:  Jianchun Xiao; Emese Prandovszky; Geetha Kannan; Mikhail V Pletnikov; Faith Dickerson; Emily G Severance; Robert H Yolken
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

2.  Optimization of dipeptidic inhibitors of cathepsin L for improved Toxoplasma gondii selectivity and CNS permeability.

Authors:  Jeffery D Zwicker; Nicolas A Diaz; Alfredo J Guerra; Paul D Kirchhoff; Bo Wen; Duxin Sun; Vern B Carruthers; Scott D Larsen
Journal:  Bioorg Med Chem Lett       Date:  2018-03-09       Impact factor: 2.823

Review 3.  Neuropathology of suicide: recent findings and future directions.

Authors:  P-E Lutz; N Mechawar; G Turecki
Journal:  Mol Psychiatry       Date:  2017-07-11       Impact factor: 15.992

Review 4.  Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity.

Authors:  Andrew J Neville; Sydney J Zach; Xiaofang Wang; Joshua J Larson; Abigail K Judge; Lisa A Davis; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

5.  Shared Immune and Repair Markers During Experimental Toxoplasma Chronic Brain Infection and Schizophrenia.

Authors:  Jakub Tomasik; Tracey L Schultz; Wolfgang Kluge; Robert H Yolken; Sabine Bahn; Vern B Carruthers
Journal:  Schizophr Bull       Date:  2015-09-20       Impact factor: 9.306

6.  Risky business: linking Toxoplasma gondii infection and entrepreneurship behaviours across individuals and countries.

Authors:  Stefanie K Johnson; Markus A Fitza; Daniel A Lerner; Dana M Calhoun; Marissa A Beldon; Elsa T Chan; Pieter T J Johnson
Journal:  Proc Biol Sci       Date:  2018-07-25       Impact factor: 5.349

7.  Expression of codon-optimized TgMIC16 in three Escherichia coli strains.

Authors:  Hui Sun; Jin Li; Gong-Zhen Liu; Kun Yin; Yong Cui; Ting Xiao; Chao Xu; Bing-Cheng Huang; Qing-Kuan Wei
Journal:  3 Biotech       Date:  2017-07-31       Impact factor: 2.406

Review 8.  Suicide and suicidal behaviour.

Authors:  Gustavo Turecki; David A Brent
Journal:  Lancet       Date:  2015-09-15       Impact factor: 79.321

9.  Antibodies directed to the gram-negative bacterium Neisseria gonorrhoeae cross-react with the 60 kDa heat shock protein and lead to impaired neurite outgrowth in NTera2/D1 cells.

Authors:  B Reuss; A R Asif
Journal:  J Mol Neurosci       Date:  2014-02-28       Impact factor: 3.444

10.  The association of Toxoplasma gondii IgG and cognitive function scores: NHANES 2013-2014.

Authors:  R Constance Wiener; Christopher Waters; Ruchi Bhandari
Journal:  Parasitol Int       Date:  2020-05-13       Impact factor: 2.230

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.